NCT07067645 Post-Hysterectomy Vaginal Length: Horizontal vs. Vertical Closure
| NCT ID | NCT07067645 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Gaziosmanpasa Research and Education Hospital |
| Condition | Prolapse, Vaginal |
| Study Type | INTERVENTIONAL |
| Enrollment | 62 participants |
| Start Date | 2025-07-01 |
| Primary Completion | 2026-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 62 participants in total. It began in 2025-07-01 with a primary completion date of 2026-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective clinical study aims to evaluate the impact of vaginal cuff closure orientation-horizontal versus vertical-on postoperative total vaginal length in patients undergoing vaginal hysterectomy combined with lateral suspension. By comparing anatomical outcomes between the two closure techniques, the study seeks to determine which method better preserves vaginal length, potentially influencing surgical preferences and postoperative quality of life.
Eligibility Criteria
Inclusion Criteria: * Cases with vaginal hysterectomy and lateral suspension surgery due to stage 3-4 uterine prolapse Agree to participate in the study and sign the informed consent form Exclusion Criteria: * Cases that have previously undergone a different suspension surgery due to descent uteri (vaginal hysterectomy and sacrospinous ligament fixation surgery, vaginal hysterectomy and sacrocolopexy surgery, vaginal hysterectomy and high sacouterin plication surgery) Cases that have undergone vaginal hysterectomy due to malignancy Cases that have undergone radiotherapy due to malignancy (brachytherapy) Patients who are not suitable for surgical intervention due to severe vaginal atrophy. Patients who will not be able to comply with the follow-up process. Not accepting to participate in the study or not signing the informed consent form
Contact & Investigator
yagmur acıyiyen, md
PRINCIPAL INVESTIGATOR
Gaziosmanpasa Training and Research Hospital
Frequently Asked Questions
Who can join the NCT07067645 clinical trial?
This trial is open to female participants only, aged 35 Years or older, up to 65 Years, studying Prolapse, Vaginal. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07067645 currently recruiting?
Yes, NCT07067645 is actively recruiting participants. Contact the research team at drserkankumbasar@gmail.com for enrollment information.
Where is the NCT07067645 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT07067645 clinical trial?
NCT07067645 is sponsored by Gaziosmanpasa Research and Education Hospital. The principal investigator is yagmur acıyiyen, md at Gaziosmanpasa Training and Research Hospital. The trial plans to enroll 62 participants.